ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
PHASE2CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
April 30, 2002
Study Completion Date
December 31, 2002
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG
ALIMTA
DRUG
Carboplatin
Trial Locations (1)
Unknown
Houston
All Listed Sponsors
lead
Eli Lilly and Company
INDUSTRY
NCT00051493 - ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. | Biotech Hunter | Biotech Hunter